Vancomycin HCl 1.5g in 250mL Sodium Chloride Injection
Fagron recalls Vancomycin HCl 1.5g/250mL injection due to sterility concern.
Do not use the recalled product. Contact Fagron Compounding Services for instructions on returning the product and obtaining a replacement or credit.
Why it was recalled
Fagron Sterile Services is recalling Vancomycin HCl 1.5 grams in 250 mL 0.9% Sodium Chloride Injection USP due to a lack of assurance of sterility. The blue break-off part could detach from the administration port, potentially compromising sterility and posing a risk of infection.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
| Product | Strength | UPC | Recall # |
|---|---|---|---|
| Vancomycin HCI, 1.5 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St… | – | 000050858, 000051018, 000049194, 000049591, 000049592, 000049823, 000050301, 000050411, 000051056 | D-0441-2026 |
| Vancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St… | – | 000050857, 000049316, 000049367, 000049496, 000049518, 000049535, 000049653, 000049654, 000049745, 000050128, 000050151, 000050184, 000050504, 000050662, 000050836, 000051014, 000051057, 000051240 | D-0440-2026 |
| norepinephrine Bitartrate | 32 mg | 000050004, 000050295, 000050773, 000051219, 000051318, 000051602 | D-0439-2026 |
| norepinephrine Bitartrate | 16 mg | 000049934, 000049963, 000050074, 000050123, 000050296, 000050420, 000050774, 000050924, 000050961, 000050991, 000051139, 000051166, 000051198, 000051343 | D-0438-2026 |
| Vancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N… | – | 000050987, 000049425, 000050069, 000050346, 000050698, 000050699, 000050775 | D-0442-2026 |
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Editorial summary by Recall Canary · summary updated 2026-09-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification